Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Semaglutide has been on the market since 2017 ... I think both drugs will sail through the FDA's approval process. I also ...

Some are small; others, biological, and there are also medications already approved for another purpose ... The most ...